Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 206

1.

Non-obese visceral adiposity is associated with the risk of atherosclerosis in Japanese patients with rheumatoid arthritis: a cross-sectional study.

Yoshida T, Hashimoto M, Kawahara R, Yamamoto H, Tanaka M, Ito H, Masuda I, Hosoda K, Yamamoto W, Uozumi R, Morita S, Fujii Y, Mimori T, Nin K.

Rheumatol Int. 2018 Jul 4. doi: 10.1007/s00296-018-4095-0. [Epub ahead of print]

PMID:
29974186
2.

Persistence of vertebral growth plate cartilage in aged cynomolgus monkeys.

Iwata M, Yamamoto W, Shimomoto T, Okada Y, Oosawa S, Miura D, Hara Y.

J Toxicol Pathol. 2018 Apr;31(2):151-154. doi: 10.1293/tox.2017-0041. Epub 2018 Feb 10.

3.

Anemia associated with worse outcome in diffuse large B-cell lymphoma patients: a single-center retrospective study.

Matsumoto K, Fujisawa S, Ando T, Koyama M, Koyama S, Ishii Y, Numata A, Yamamoto W, Motohashi K, Hagihara M, Nakajima H.

Turk J Haematol. 2018 Mar 28. doi: 10.4274/tjh.2017.0437. [Epub ahead of print] No abstract available.

4.

Drug retention and discontinuation reasons between seven biologics in patients with rheumatoid arthritis -The ANSWER cohort study.

Ebina K, Hashimoto M, Yamamoto W, Ohnishi A, Kabata D, Hirano T, Hara R, Katayama M, Yoshida S, Nagai K, Son Y, Amuro H, Akashi K, Fujimura T, Hirao M, Yamamoto K, Shintani A, Kumanogoh A, Yoshikawa H.

PLoS One. 2018 Mar 15;13(3):e0194130. doi: 10.1371/journal.pone.0194130. eCollection 2018.

5.

Distinct roles for plasma membrane PtdIns(4)P and PtdIns(4,5)P2 during receptor-mediated endocytosis in yeast.

Yamamoto W, Wada S, Nagano M, Aoshima K, Siekhaus DE, Toshima JY, Toshima J.

J Cell Sci. 2018 Jan 4;131(1). pii: jcs207696. doi: 10.1242/jcs.207696.

6.

The Serum Level of KL-6 Is Associated with the Risk of Insulin Resistance and New-onset Diabetes Mellitus: The Tanno-Sobetsu Study.

Akasaka H, Ohnishi H, Narita Y, Kameda M, Miki T, Takahashi H, Yamamoto W, Sohma H, Masumori N, Miura T; SPRUCE project investigators.

Intern Med. 2017 Nov 15;56(22):3009-3018. doi: 10.2169/internalmedicine.8716-16. Epub 2017 Sep 25.

7.

Importance of the alignment of polar π conjugated molecules inside carbon nanotubes in determining second-order non-linear optical properties.

Yumura T, Yamamoto W.

Phys Chem Chem Phys. 2017 Sep 20;19(36):24819-24828. doi: 10.1039/c7cp03128a.

PMID:
28868534
8.

IL-6 is an independent predictive factor of drug survival after dose escalation of infliximab in patients with rheumatoid arthritis.

Takasugi K, Nishida K, Natsumeda M, Yamashita M, Yamamoto W, Ezawa K.

Mod Rheumatol. 2018 May;28(3):452-460. doi: 10.1080/14397595.2017.1361802. Epub 2017 Aug 22.

PMID:
28828944
9.

Time-averaged disease activity fits better joint destruction in rheumatoid arthritis.

Tsuji H, Yano K, Furu M, Yamakawa N, Ikari K, Hashimoto M, Ito H, Fujii T, Yamamoto W, Ohmura K, Taniguchi A, Momohara S, Matsuda F, Allaart CF, Yamanaka H, Mimori T, Terao C.

Sci Rep. 2017 Jul 19;7(1):5856. doi: 10.1038/s41598-017-05581-w.

10.

Accuracy of J-CTO Score Derived From Computed Tomography Versus Angiography to Predict Successful Percutaneous Coronary Intervention.

Fujino A, Otsuji S, Hasegawa K, Arita T, Takiuchi S, Fujii K, Yabuki M, Ibuki M, Nagayama S, Ishibuchi K, Kashiyama T, Ishii R, Tamaru H, Yamamoto W, Hara M, Higashino Y.

JACC Cardiovasc Imaging. 2018 Feb;11(2 Pt 1):209-217. doi: 10.1016/j.jcmg.2017.01.028. Epub 2017 Jun 14.

PMID:
28624404
11.

The standard international prognostic index for predicting the risk of CNS involvement in DLBCL without specific prophylaxis.

Tomita N, Yokoyama M, Yamamoto W, Watanabe R, Shimazu Y, Masaki Y, Tsunoda S, Hashimoto C, Murayama K, Yano T, Okamoto R, Kikuchi A, Tamura K, Sato K, Sunami K, Shibayama H, Takimoto R, Ohshima R, Takahashi H, Moriuchi Y, Kinoshita T, Yamamoto M, Numata A, Nakajima H, Miura I, Takeuchi K.

Leuk Lymphoma. 2018 Jan;59(1):97-104. doi: 10.1080/10428194.2017.1330541. Epub 2017 Jun 8.

PMID:
28593796
12.

CSAHi study: Detection of drug-induced ion channel/receptor responses, QT prolongation, and arrhythmia using multi-electrode arrays in combination with human induced pluripotent stem cell-derived cardiomyocytes.

Kitaguchi T, Moriyama Y, Taniguchi T, Maeda S, Ando H, Uda T, Otabe K, Oguchi M, Shimizu S, Saito H, Toratani A, Asayama M, Yamamoto W, Matsumoto E, Saji D, Ohnaka H, Miyamoto N.

J Pharmacol Toxicol Methods. 2017 May - Jun;85:73-81. doi: 10.1016/j.vascn.2017.02.001. Epub 2017 Feb 3.

PMID:
28163191
13.

Body mass index is a prognostic factor in adult patients with acute myeloid leukemia.

Ando T, Yamazaki E, Ogusa E, Ishii Y, Yamamoto W, Motohashi K, Tachibana T, Hagihara M, Matsumoto K, Tanaka M, Hashimoto C, Koharazawa H, Fujimaki K, Taguchi J, Fujita H, Kanamori H, Fujisawa S, Nakajima H; Yokohama Cooperative Study Group for Hematology (YACHT).

Int J Hematol. 2017 May;105(5):623-630. doi: 10.1007/s12185-017-2183-7. Epub 2017 Jan 21.

PMID:
28110409
14.

Relationship between handedness and joint involvement in rheumatoid arthritis.

Yaku A, Hashimoto M, Furu M, Ito H, Yamakawa N, Yamamoto W, Fujii T, Matsuda F, Mimori T, Terao C.

Sci Rep. 2016 Dec 15;6:39180. doi: 10.1038/srep39180.

15.

A new paradigm for drug-induced torsadogenic risk assessment using human iPS cell-derived cardiomyocytes.

Ando H, Yoshinaga T, Yamamoto W, Asakura K, Uda T, Taniguchi T, Ojima A, Shinkyo R, Kikuchi K, Osada T, Hayashi S, Kasai C, Miyamoto N, Tashibu H, Yamazaki D, Sugiyama A, Kanda Y, Sawada K, Sekino Y.

J Pharmacol Toxicol Methods. 2017 Mar - Apr;84:111-127. doi: 10.1016/j.vascn.2016.12.003. Epub 2016 Dec 10.

16.

Electrophysiological Characteristics of Human iPSC-Derived Cardiomyocytes for the Assessment of Drug-Induced Proarrhythmic Potential.

Yamamoto W, Asakura K, Ando H, Taniguchi T, Ojima A, Uda T, Osada T, Hayashi S, Kasai C, Miyamoto N, Tashibu H, Yoshinaga T, Yamazaki D, Sugiyama A, Kanda Y, Sawada K, Sekino Y.

PLoS One. 2016 Dec 6;11(12):e0167348. doi: 10.1371/journal.pone.0167348. eCollection 2016.

17.

Outcome and prognostic factors among patients who underwent a second transplantation for disease relapse post the first allogeneic cell transplantation.

Tachibana T, Matsumoto K, Tanaka M, Hagihara M, Motohashi K, Yamamoto W, Ogusa E, Koyama S, Numata A, Tomita N, Taguchi J, Fujisawa S, Kanamori H, Nakajima H.

Leuk Lymphoma. 2017 Jun;58(6):1403-1411. doi: 10.1080/10428194.2016.1243678. Epub 2016 Oct 14.

PMID:
27739916
18.

Development of pulmonary arterial hypertension during oral dasatinib therapy for chronic myelogenous leukemia.

Morishita S, Hagihara M, Itabashi M, Ishii Y, Yamamoto W, Numata A, Motohashi K, Matsumoto K, Fujisawa S, Nakajima H.

Rinsho Ketsueki. 2016 Aug;57(8):999-1003. doi: 10.11406/rinketsu.57.999. Review. Japanese.

PMID:
27599415
19.

SERCA2 Deficiency Impairs Pancreatic β-Cell Function in Response to Diet-Induced Obesity.

Tong X, Kono T, Anderson-Baucum EK, Yamamoto W, Gilon P, Lebeche D, Day RN, Shull GE, Evans-Molina C.

Diabetes. 2016 Oct;65(10):3039-52. doi: 10.2337/db16-0084. Epub 2016 Aug 3.

20.

Allogeneic Hematopoietic Stem Cell Transplantation after Conditioning Regimens with Fludarabine/melphalan or Fludarabine/busulfan for Patients with Hematological Malignancies: A Single-center Analysis.

Yamamoto W, Andou T, Itabashi M, Koyama S, Ishii Y, Numata A, Motohashi K, Hagihara M, Matsumoto K, Fujisawa S.

Intern Med. 2016;55(13):1721-7. doi: 10.2169/internalmedicine.55.6094. Epub 2016 Jul 1.

21.

The SIL index is a simple and objective prognostic indicator in diffuse large B-cell lymphoma.

Tomita N, Suzuki T, Miyashita K, Yamamoto W, Motohashi K, Tachibana T, Takasaki H, Kawasaki R, Hagihara M, Hashimoto C, Takemura S, Koharazawa H, Yamazaki E, Taguchi J, Fujimaki K, Fujita H, Sakai R, Fujisawa S, Motomura S, Kawamoto K, Sone H, Takizawa J.

Leuk Lymphoma. 2016 Dec;57(12):2763-2770. Epub 2016 Jun 20.

PMID:
27320054
22.

Hyper-recovery of platelets after induction therapy is a predictor of relapse-free survival in acute myeloid leukemia.

Yamazaki E, Kanamori H, Itabashi M, Ogusa E, Numata A, Yamamoto W, Ito S, Tachibana T, Hagihara M, Matsumoto K, Koharazawa H, Taguchi J, Tomita N, Fujimaki K, Fujita H, Fujisawa S, Ogawa K, Ishigatsubo Y.

Leuk Lymphoma. 2017 Jan;58(1):104-109. Epub 2016 Jun 7.

PMID:
27267543
23.

Retrospective Study of Incidence and Prognostic Significance of Eosinophilia after Allogeneic Hematopoietic Stem Cell Transplantation: Influence of Corticosteroid Therapy.

Yamamoto W, Ogusa E, Matsumoto K, Maruta A, Ishigatsubo Y, Kanamori H.

Turk J Haematol. 2016 Sep 5;33(3):196-201. doi: 10.4274/tjh.2015.0047. Epub 2016 Apr 18.

24.

Favorable prognosis in Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia patients following hematopoietic stem cell transplantation.

Numata A, Fujisawa S, Itabashi M, Ishii Y, Yamamoto W, Motohashi K, Matsumoto K, Hagihara M, Nakajima H.

Clin Transplant. 2016 May;30(5):485-6. doi: 10.1111/ctr.12702. Epub 2016 Mar 14. No abstract available.

PMID:
26990549
25.

Cytomegalovirus Pneumonia after Anti-CC-chemokine Receptor 4 Monoclonal Antibody (Mogamulizumab) Therapy in an Angioimmunoblastic T-cell Lymphoma Patient.

Ishii Y, Itabashi M, Numata A, Yamamoto W, Motohashi K, Hagihara M, Matsumoto K, Fujisawa S.

Intern Med. 2016;55(6):673-5. doi: 10.2169/internalmedicine.55.5644. Epub 2016 Mar 15.

26.

Prognostic value of pretransplant serum C-reactive protein in patients receiving reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation.

Yamamoto W, Fujii E, Matsumoto K, Yamamoto E, Aoki J, Tanaka M, Ishigatsubo Y, Kanamori H.

Int J Hematol. 2016 Apr;103(4):444-52. doi: 10.1007/s12185-016-1941-2. Epub 2016 Jan 20.

PMID:
26791379
27.

The association between serious infection and disease outcome in patients with rheumatoid arthritis.

Iguchi-Hashimoto M, Hashimoto M, Fujii T, Hamaguchi M, Furu M, Ishikawa M, Ito H, Yamakawa N, Terao C, Yamamoto K, Yamamoto W, Ohmura K, Mimori T.

Clin Rheumatol. 2016 Jan;35(1):213-8. doi: 10.1007/s10067-015-3143-3. Epub 2015 Dec 17.

PMID:
26676809
28.

CSAHi study: Evaluation of multi-electrode array in combination with human iPS cell-derived cardiomyocytes to predict drug-induced QT prolongation and arrhythmia--effects of 7 reference compounds at 10 facilities.

Kitaguchi T, Moriyama Y, Taniguchi T, Ojima A, Ando H, Uda T, Otabe K, Oguchi M, Shimizu S, Saito H, Morita M, Toratani A, Asayama M, Yamamoto W, Matsumoto E, Saji D, Ohnaka H, Tanaka K, Washio I, Miyamoto N.

J Pharmacol Toxicol Methods. 2016 Mar-Apr;78:93-102. doi: 10.1016/j.vascn.2015.12.002. Epub 2015 Dec 4.

PMID:
26657830
29.

The bridge treatment selected at the decision for transplantation did not affect the outcomes in patients with MDS.

Kako S, Kanda Y, Kato J, Yamamoto W, Kato S, Onizuka M, Yokota A, Tatara R, Yokoyama H, Hagihara M, Usuki K, Gotoh M, Watanabe R, Kawai N, Saitoh T, Kanamori H, Takahashi S, Okamoto S.

Hematol Oncol. 2017 Sep;35(3):341-349. doi: 10.1002/hon.2276. Epub 2015 Dec 8.

PMID:
26643559
30.

Srv2/CAP is required for polarized actin cable assembly and patch internalization during clathrin-mediated endocytosis.

Toshima JY, Horikomi C, Okada A, Hatori MN, Nagano M, Masuda A, Yamamoto W, Siekhaus DE, Toshima J.

J Cell Sci. 2016 Jan 15;129(2):367-79. doi: 10.1242/jcs.176651. Epub 2015 Nov 24.

31.

Beta-2 microglobulin is a strong prognostic factor in patients with DLBCL receiving R-CHOP therapy.

Miyashita K, Tomita N, Taguri M, Suzuki T, Ishiyama Y, Ishii Y, Nakajima Y, Numata A, Hattori Y, Yamamoto W, Miyazaki T, Tachibana T, Takasaki H, Matsumoto K, Hashimoto C, Takemura S, Yamazaki E, Fujimaki K, Sakai R, Motomura S, Ishigatsubo Y.

Leuk Res. 2015 Aug 29. pii: S0145-2126(15)30368-4. doi: 10.1016/j.leukres.2015.08.016. [Epub ahead of print]

PMID:
26350140
32.

Prophylactic treatment with sulphonated immunoglobulin G attenuates development of mechanical allodynia-like response in mice with neuropathic pain.

Yamamoto W, Itano Y, Kobayashi T, Miura D, Kasahara Y.

J Vet Med Sci. 2016 Jan;78(1):77-82. doi: 10.1292/jvms.15-0195. Epub 2015 Aug 29.

33.

Evaluation of soluble interleukin-2 receptor and serum lactate dehydrogenase in malignant lymphoma.

Tomita N, Taguri M, Hashimoto C, Takasaki H, Fujimaki K, Motomura S, Koharazawa H, Takemura S, Fujita H, Yamazaki E, Kawasaki R, Taguchi J, Sakai R, Fujisawa S, Hattori Y, Kanamori H, Yamamoto W, Harano H, Ogawa K, Ishigatsubo Y.

Ann Hematol. 2015 Nov;94(11):1935-7. doi: 10.1007/s00277-015-2448-2. Epub 2015 Jul 25. No abstract available.

PMID:
26208667
34.

Musculoskeletal pain may be associated with imatinib withdrawal syndrome in chronic myeloid leukemia patients.

Ishii Y, Hagihara M, Kato A, Ando T, Itabashi M, Koyama S, Yamamoto W, Motohashi K, Matsumoto K, Fujisawa S.

Leuk Lymphoma. 2015 Oct 1:1-2. [Epub ahead of print] No abstract available.

PMID:
26098014
35.

Post-treatment PET-CT Findings may Predict the Prognosis of DLBCL with a Bulky Mass.

Takasaki H, Yamamoto W, Ishii Y, Takahashi H, Watanabe R, Harada T, Kawasaki R, Hashimoto C, Motomura S, Tomita N, Ishigatsubo Y, Sakai R.

Indian J Hematol Blood Transfus. 2015 Sep;31(3):346-51. doi: 10.1007/s12288-014-0479-9. Epub 2014 Dec 3.

36.

Emergence of del(20q) in a patient in molecular remission of chronic myelogenous leukemia during imatinib treatment, with reduction following imatinib discontinuation.

Numata A, Kajiyama R, Itabashi M, Ishii Y, Yamamoto W, Motohashi K, Matsumoto K, Hagihara M, Ishigatsubo Y, Fujisawa S.

Leuk Lymphoma. 2016;57(1):201-2. doi: 10.3109/10428194.2015.1037763. Epub 2015 May 12. No abstract available.

PMID:
25860242
37.

Periodontitis and Porphyromonas gingivalis in preclinical stage of arthritis patients.

Hashimoto M, Yamazaki T, Hamaguchi M, Morimoto T, Yamori M, Asai K, Isobe Y, Furu M, Ito H, Fujii T, Terao C, Mori M, Matsuo T, Yoshitomi H, Yamamoto K, Yamamoto W, Bessho K, Mimori T.

PLoS One. 2015 Apr 7;10(4):e0122121. doi: 10.1371/journal.pone.0122121. eCollection 2015.

38.

Pancreatic and duodenal homeobox protein 1 (Pdx-1) maintains endoplasmic reticulum calcium levels through transcriptional regulation of sarco-endoplasmic reticulum calcium ATPase 2b (SERCA2b) in the islet β cell.

Johnson JS, Kono T, Tong X, Yamamoto WR, Zarain-Herzberg A, Merrins MJ, Satin LS, Gilon P, Evans-Molina C.

J Biol Chem. 2014 Nov 21;289(47):32798-810. doi: 10.1074/jbc.M114.575191. Epub 2014 Sep 30.

39.

Increase of hemoglobin levels by anti-IL-6 receptor antibody (tocilizumab) in rheumatoid arthritis.

Hashimoto M, Fujii T, Hamaguchi M, Furu M, Ito H, Terao C, Yamamoto K, Yamamoto W, Matsuo T, Mori M, Ohmura K, Kawabata H, Mimori T.

PLoS One. 2014 May 30;9(5):e98202. doi: 10.1371/journal.pone.0098202. eCollection 2014.

40.

Predictive value of risk assessment scores in patients with hematologic malignancies undergoing reduced-intensity conditioning allogeneic stem cell transplantation.

Yamamoto W, Ogusa E, Matsumoto K, Maruta A, Ishigatsubo Y, Kanamori H.

Am J Hematol. 2014 Sep;89(9):E138-41. doi: 10.1002/ajh.23764. Epub 2014 Jun 20.

41.

Effects of the selective KACh channel blocker NTC-801 on atrial fibrillation in a canine model of atrial tachypacing: comparison with class Ic and III drugs.

Yamamoto W, Hashimoto N, Matsuura J, Machida T, Ogino Y, Kobayashi T, Yamanaka Y, Ishiwata N, Yamashita T, Tanimoto K, Miyoshi S, Fukuda K, Nakaya H, Ogawa S.

J Cardiovasc Pharmacol. 2014 May;63(5):421-7. doi: 10.1097/FJC.0000000000000065.

PMID:
24805146
42.

[Clinical evaluation of lapatinib therapy in metastatic breast cancer using the Bayes meta-analysis].

Inoue T, Iyoda T, Yamamoto W, Uetsuka Y.

Gan To Kagaku Ryoho. 2014 Mar;41(3):347-52. Japanese.

PMID:
24743281
43.

Bifurcation of the endocytic pathway into Rab5-dependent and -independent transport to the vacuole.

Toshima JY, Nishinoaki S, Sato Y, Yamamoto W, Furukawa D, Siekhaus DE, Sawaguchi A, Toshima J.

Nat Commun. 2014 Mar 25;5:3498. doi: 10.1038/ncomms4498.

PMID:
24667230
44.

Disseminated Cunninghamella bertholletiae infection with septic pulmonary embolism after allogeneic bone marrow transplantation.

Matsumoto K, Yamamoto W, Ohgusa E, Tanaka M, Maruta A, Ishigatsubo Y, Kanamori H.

Transpl Infect Dis. 2014 Apr;16(2):304-6. doi: 10.1111/tid.12190. Epub 2014 Mar 5.

PMID:
24593246
45.

Human herpesvirus-6 encephalopathy after hematopoietic stem cell transplantation and class I human leukocyte antigen.

Yamamoto W, Ogusa E, Matsumoto K, Maruta A, Ishigatsubo Y, Kanamori H.

Clin Transplant. 2014 May;28(5):540-5. doi: 10.1111/ctr.12342. Epub 2014 Apr 2.

PMID:
24579822
46.

Prognostic index for relapsed acute leukemia after allogeneic stem cell transplant.

Matsumoto K, Yamamoto W, Ogusa E, Ishigatsubo Y, Kanamori H.

Leuk Lymphoma. 2014 Dec;55(12):2808-12. doi: 10.3109/10428194.2014.896004. Epub 2014 Apr 2.

PMID:
24555841
47.

Human leukocyte antigen-DR expression on flow cytometry and tumor-associated macrophages in diffuse large B-cell lymphoma treated by rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone therapy: retrospective cohort study.

Yamamoto W, Nakamura N, Tomita N, Takeuchi K, Ishii Y, Takahashi H, Watanabe R, Takasaki H, Motomura S, Kobayashi S, Yokose T, Ishigatsubo Y, Sakai R.

Leuk Lymphoma. 2014 Dec;55(12):2721-7. doi: 10.3109/10428194.2014.893311. Epub 2014 Mar 19.

PMID:
24528218
48.

Human adipose-derived stromal/stem cells protect against STZ-induced hyperglycemia: analysis of hASC-derived paracrine effectors.

Kono TM, Sims EK, Moss DR, Yamamoto W, Ahn G, Diamond J, Tong X, Day KH, Territo PR, Hanenberg H, Traktuev DO, March KL, Evans-Molina C.

Stem Cells. 2014 Jul;32(7):1831-42. doi: 10.1002/stem.1676.

49.

Biweekly THP-COP therapy for newly diagnosed peripheral T-cell lymphoma patients.

Tomita N, Kodama F, Tsuyama N, Sakata S, Takeuchi K, Ishibashi D, Koyama S, Ishii Y, Yamamoto W, Takasaki H, Hagihara M, Kuwabara H, Tanaka M, Hashimoto C, Yamazaki E, Koharazawa H, Fujimaki K, Sakai R, Fujisawa S, Ishigatsubo Y.

Hematol Oncol. 2015 Mar;33(1):9-14. doi: 10.1002/hon.2136. Epub 2014 Feb 11.

PMID:
24519501
50.

Recovery of natural killer cells and prognosis after cord blood transplantation.

Yamamoto W, Ogusa E, Matsumoto K, Maruta A, Ishigatsubo Y, Kanamori H.

Leuk Res. 2013 Nov;37(11):1522-6. doi: 10.1016/j.leukres.2013.09.005. Epub 2013 Sep 18.

PMID:
24095583

Supplemental Content

Loading ...
Support Center